Search

Your search keyword '"Furuya, Katryn N."' showing total 144 results

Search Constraints

Start Over You searched for: Author "Furuya, Katryn N." Remove constraint Author: "Furuya, Katryn N."
144 results on '"Furuya, Katryn N."'

Search Results

2. Colorectal Dysplasia and Cancer in Pediatric-Onset Ulcerative Colitis Associated With Primary Sclerosing Cholangitis

3. Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis‐associated inflammatory bowel disease (PSC‐IBD): A matched analysis from the Paediatric PSC Consortium.

6. Frailty in Children with Liver Disease: A Prospective Multicenter Study

7. Vedolizumab Therapy in Children With Primary Sclerosing Cholangitis: Data From the Pediatric Primary Sclerosing Cholangitis Consortium

8. Assessing the Validity of Adult-derived Prognostic Models for Primary Sclerosing Cholangitis Outcomes in Children

9. Turner syndrome may be associated with hepatic adenoma.

14. Hemosuccus Pancreaticus Following Acute Pancreatitis in a 12-years-old Boy Secondary to Pancreatic Pseudoaneurysm Treated With Endovascular Coil Embolization

15. Recurrence of Primary Sclerosing Cholangitis After Liver Transplant in Children: An International Observational Study

16. A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency

18. Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis

19. The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for Children

20. The SPLIT Research Agenda 2013

22. Normal liver stiffness and influencing factors in healthy children: An individual participant data meta‐analysis

24. Diffuse Adenomatosis and Hepatocellular Carcinoma Treated with Liver Transplantation in an Adolescent Female with Kabuki Syndrome with a Novel KMT2D Gene Mutation

25. Mesenchymal Hamartoma in Children: A Diagnostic Challenge

26. The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for Children.

28. Homozygosity for a mutation affecting the catalytic domain of tyrosyl-tRNA synthetase (YARS) causes multisystem disease

29. Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing Cholangitis

31. THE AUTHORS REPLY.

32. The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration

34. Novel Mutation in a Patient with Cholesterol Ester Storage Disease

35. Results of a Global Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Sebelipase Alfa as an Enzyme Replacement Therapy in Children and Adults with Lysosomal Acid Lipase Deficiency

36. Homozygosity for a mutation affecting the catalytic domain of tyrosyl-tRNA synthetase (YARS) causes multisystem disease.

49. Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing Cholangitis

50. The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration

Catalog

Books, media, physical & digital resources